| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VIROL.2004.01.008 |
| P8608 | Fatcat ID | release_5p5z5srxqneqbc4ifmik4z57xu |
| P698 | PubMed publication ID | 15063116 |
| P5875 | ResearchGate publication ID | 8638688 |
| P50 | author | Ratna B Ray | Q90724777 |
| P2093 | author name string | Robert Steele | |
| Ranjit Ray | |||
| Asish K Ghosh | |||
| Bhaswati Sarcar | |||
| P2860 | cites work | NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling | Q22009551 |
| Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein | Q22010735 | ||
| Hepatitis C virus NS5A protein modulates transcription through a novel cellular transcription factor SRCAP | Q22253279 | ||
| Nonstructural protein 5A of hepatitis C virus inhibits the function of karyopherin beta3 | Q22254038 | ||
| Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway | Q24531184 | ||
| Activation and association of Stat3 with Src in v-Src-transformed cell lines | Q24650319 | ||
| Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response | Q27469808 | ||
| Persistent and transient replication of full-length hepatitis C virus genomes in cell culture | Q27472869 | ||
| Subversion of Cell Signaling Pathways by Hepatitis C Virus Nonstructural 5A Protein via Interaction with Grb2 and P85 Phosphatidylinositol 3-Kinase | Q27472897 | ||
| Activation of STAT3 by the Hepatitis C Virus Core Protein Leads to Cellular Transformation | Q27485121 | ||
| Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis | Q27860603 | ||
| Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome | Q27860719 | ||
| Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins | Q27860890 | ||
| Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation | Q28288257 | ||
| Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6 | Q28637521 | ||
| STATs and gene regulation | Q29547796 | ||
| STATs in oncogenesis | Q29617571 | ||
| Transcriptional responses to polypeptide ligands: the JAK-STAT pathway | Q29620287 | ||
| Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner | Q33836415 | ||
| Association of STATs with relatives and friends | Q33838284 | ||
| Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. | Q33933056 | ||
| The role of STATs in transcriptional control and their impact on cellular function | Q33941346 | ||
| Cytokine signaling in 2002: new surprises in the Jak/Stat pathway | Q34126053 | ||
| The origin and evolution of hepatitis viruses in humans | Q34189077 | ||
| The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors | Q36684890 | ||
| Activation of Stat3 in v-Src-transformed fibroblasts requires cooperation of Jak1 kinase activity | Q38312043 | ||
| Opposite regulation of myc and p21waf1 transcription by STAT3 proteins | Q38360847 | ||
| Constitutively Activated Jak-STAT Pathway in T Cells Transformed with HTLV-I | Q39250459 | ||
| Stat3 activation by Src induces specific gene regulation and is required for cell transformation | Q39583802 | ||
| Cytoplasmic transport of Stat3 by receptor-mediated endocytosis | Q39647602 | ||
| Cytokine receptor signalling | Q40416594 | ||
| Inhibition of hepatitis C virus protein expression by RNA interference | Q40638524 | ||
| HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis | Q40720204 | ||
| Kaposi's Sarcoma-associated herpesvirus open reading frame 50 stimulates the transcriptional activity of STAT3. | Q40763723 | ||
| Hepatitis C virus NS5A protein protects against TNF-alpha mediated apoptotic cell death | Q40871684 | ||
| Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein | Q41326706 | ||
| Production of two phosphoproteins from the NS5A region of the hepatitis C viral genome. | Q42596301 | ||
| MBP-1 mediated apoptosis involves cytochrome c release from mitochondria | Q42815963 | ||
| Hepatitis C virus NS5A protein modulates cell cycle regulatory genes and promotes cell growth | Q42993783 | ||
| Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice | Q45733379 | ||
| Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor | Q68007089 | ||
| Molecular virology of hepatitis C virus | Q73829009 | ||
| PTEN transcriptionally modulates c-myc gene expression in human breast carcinoma cells and is involved in cell growth regulation | Q78026206 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Hepatitis C virus | Q708693 |
| P304 | page(s) | 51-60 | |
| P577 | publication date | 2004-04-01 | |
| P1433 | published in | Virology | Q7934867 |
| P1476 | title | Hepatitis C virus NS5A mediated STAT3 activation requires co-operation of Jak1 kinase | |
| P478 | volume | 322 |
| Q26741576 | A Central Role for STAT3 in Gammaherpesvirus-Life Cycle and -Diseases |
| Q35954415 | Altered p-STAT3 (tyr705) expression is associated with histological grading and intratumour microvessel density in hepatocellular carcinoma |
| Q27487944 | Arsenic Trioxide Inhibits Hepatitis C Virus RNA Replication through Modulation of the Glutathione Redox System and Oxidative Stress |
| Q40786667 | Differential association of STAT3 and HK-II expression in hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma |
| Q83856045 | Downregulation of GRIM-19 is associated with hyperactivation of p-STAT3 in hepatocellular carcinoma |
| Q29618976 | Evasion of intracellular host defence by hepatitis C virus |
| Q27487140 | Hepatitis C Virus Core Protein Augments Androgen Receptor-Mediated Signaling |
| Q27469443 | Hepatitis C virus NS5A-mediated activation of phosphoinositide 3-kinase results in stabilization of cellular beta-catenin and stimulation of beta-catenin-responsive transcription |
| Q36397362 | Hepatitis C virus activates Bcl-2 and MMP-2 expression through multiple cellular signaling pathways |
| Q56917098 | Hepatitis C virus and hepatocellular carcinoma |
| Q36935539 | Hepatitis C virus infection and apoptosis |
| Q42991206 | Hepatitis C virus targets the interferon-α JAK/STAT pathway by promoting proteasomal degradation in immune cells and hepatocytes |
| Q33779089 | Hepcidin and the iron enigma in HCV infection |
| Q36124729 | Host cell targets in HCV therapy: novel strategy or proven practice? |
| Q33303326 | Identification of human kinases involved in hepatitis C virus replication by small interference RNA library screening. |
| Q27489517 | Inhibition of Intrahepatic Gamma Interferon Production by Hepatitis C Virus Nonstructural Protein 5A in Transgenic Mice |
| Q45375947 | Inhibition of the interferon antiviral response by hepatitis C virus |
| Q40000685 | Isolation and gene analysis of interferon alpha-resistant cell clones of the hepatitis C virus subgenome |
| Q96768636 | Natural cardenolides suppress coronaviral replication by downregulating JAK1 via a Na+/K+-ATPase independent proteolysis |
| Q37574403 | Neurotoxic effects of the HCV core protein are mediated by sustained activation of ERK via TLR2 signaling |
| Q36841728 | New animal models for hepatitis C viral infection and pathogenesis studies |
| Q36255920 | Nonstructural 5A Protein of Hepatitis C Virus Interferes with Toll-Like Receptor Signaling and Suppresses the Interferon Response in Mouse Liver |
| Q35261292 | Oncogenic potential of hepatitis C virus proteins |
| Q40923110 | PI3K-Akt signaling pathway upregulates hepatitis C virus RNA translation through the activation of SREBPs |
| Q45399951 | Role of hepatitis C virus proteins (C, NS3, NS5A) in hepatic oncogenesis |
| Q38304391 | Role of signal transducer and activator of transcription 3 in liver fibrosis progression in chronic hepatitis C-infected patients |
| Q90576848 | STAT3 roles in viral infection: antiviral or proviral? |
| Q38271793 | TLR4-dependent tumor-initiating stem cell-like cells (TICs) in alcohol-associated hepatocellular carcinogenesis |
| Q52655043 | The IL-6/STAT3 pathway upregulates microRNA-125b expression in hepatitis C virus infection. |
| Q33911621 | The oncogenic role of NS5A of hepatitis C virus is mediated by up-regulation of survivin gene expression in the hepatocellular cell through p53 and NF-κB pathways |
| Q39672712 | The role of signal transducer and activator of transcription 3 in Rift Valley fever virus infection |
Search more.